BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11051267)

  • 21. Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G.
    Soh JW; Kazi JU; Li H; Thompson WJ; Weinstein IB
    Mol Carcinog; 2008 Jul; 47(7):519-25. PubMed ID: 18163459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells.
    Yoon JT; Palazzo AF; Xiao D; Delohery TM; Warburton PE; Bruce JN; Thompson WJ; Sperl G; Whitehead C; Fetter J; Pamukcu R; Gundersen GG; Weinstein IB
    Mol Cancer Ther; 2002 Apr; 1(6):393-404. PubMed ID: 12477052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.
    Thompson WJ; Piazza GA; Li H; Liu L; Fetter J; Zhu B; Sperl G; Ahnen D; Pamukcu R
    Cancer Res; 2000 Jul; 60(13):3338-42. PubMed ID: 10910034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro-apoptotic actions of exisulind and CP461 in SW480 colon tumor cells involve beta-catenin and cyclin D1 down-regulation.
    Li H; Liu L; David ML; Whitehead CM; Chen M; Fetter JR; Sperl GJ; Pamukcu R; Thompson WJ
    Biochem Pharmacol; 2002 Nov; 64(9):1325-36. PubMed ID: 12392815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolactin stimulates activation of c-jun N-terminal kinase (JNK).
    Schwertfeger KL; Hunter S; Heasley LE; Levresse V; Leon RP; DeGregori J; Anderson SM
    Mol Endocrinol; 2000 Oct; 14(10):1592-602. PubMed ID: 11043575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SEK1-dependent JNK1 activation prolongs cell survival during G-Rh2-induced apoptosis.
    Ham YM; Chun KH; Choi JS; Kim DH; Lee SK
    Biochem Biophys Res Commun; 2003 May; 304(2):358-64. PubMed ID: 12711323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulindac and its derivatives: a novel class of anticancer agents.
    Haanen C
    Curr Opin Investig Drugs; 2001 May; 2(5):677-83. PubMed ID: 11569947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G.
    Tinsley HN; Gary BD; Keeton AB; Zhang W; Abadi AH; Reynolds RC; Piazza GA
    Mol Cancer Ther; 2009 Dec; 8(12):3331-40. PubMed ID: 19996273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling.
    Li N; Xi Y; Tinsley HN; Gurpinar E; Gary BD; Zhu B; Li Y; Chen X; Keeton AB; Abadi AH; Moyer MP; Grizzle WE; Chang WC; Clapper ML; Piazza GA
    Mol Cancer Ther; 2013 Sep; 12(9):1848-59. PubMed ID: 23804703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G(2)-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells.
    Moon EY; Lerner A
    Cancer Res; 2002 Oct; 62(20):5711-9. PubMed ID: 12384529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of MAP kinases and their cross-talk in TGF-beta1-induced apoptosis in FaO rat hepatoma cell line.
    Park HJ; Kim BC; Kim SJ; Choi KS
    Hepatology; 2002 Jun; 35(6):1360-71. PubMed ID: 12029621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization.
    Xiao D; Deguchi A; Gundersen GG; Oehlen B; Arnold L; Weinstein IB
    Mol Cancer Ther; 2006 Jan; 5(1):60-7. PubMed ID: 16432163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis.
    Shimada K; Matsuyoshi S; Nakamura M; Ishida E; Kishi M; Konishi N
    Carcinogenesis; 2004 Jul; 25(7):1089-97. PubMed ID: 15001534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.
    Jin HO; Seo SK; Woo SH; Lee HC; Kim ES; Yoo DH; Lee SJ; An S; Choe TB; Kim JI; Hong SI; Rhee CH; Park IC
    Lung Cancer; 2008 Sep; 61(3):317-27. PubMed ID: 18281123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation.
    Xiao D; Pinto JT; Soh JW; Deguchi A; Gundersen GG; Palazzo AF; Yoon JT; Shirin H; Weinstein IB
    Cancer Res; 2003 Oct; 63(20):6825-37. PubMed ID: 14583480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells.
    Elder DJ; Halton DE; Playle LC; Paraskeva C
    Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.